Notícias e Atividades da Phio Pharmaceuticals

Phio Pharmaceuticals é uma empresa listada sob o símbolo PHIO (US).

Veja o organograma con seus 10 executivos principais

Biografias mais buscadas da Phio Pharmaceuticals

• Robert Bitterman, Chairman of the Board and Chief Executive Officer
• Jonathan Freeman, Independent Director
• Robert Ferrara, Director

Recentes movimentos de executivos em Phio Pharmaceuticals

• David Deming, ingressou na Companhia como Lead Independent Director  (Notícia publicada em 31 de outubro de 2025).

Criar um alerta
para seguir os movimentos de executivos da Phio Pharmaceuticals.

Phio Pharmaceuticals possui 2.405 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e BioNTech (Alemanha).

Popular M&A news in Biotecnologia

• IMU Biosciences acaba de anunciar uma arrecadação de fundos de 53 milhões de dólares. (publicado em 3 de junho de 2026).
• NewLimit acaba de anunciar uma arrecadação de fundos de 435 milhões de dólares. (publicado em 3 de junho de 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (publicado em 1 de junho de 2026)..

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Valerie Hanote - Non-Executive Director da Eurofins

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Phio Pharmaceuticals

• Press Releases - Phio Pharmaceuticals
• Phio Pharmaceuticals Presents Study Outline of Its First Clinical Trial with PH-762 for Advanced Melanoma at the 2022 ASCO Annual Meeting | Phio Pharmaceuticals
• Phio Pharmaceuticals Presents New Data Demonstrating PH-894 Enhances Activity of HER2-CAR-T Cells at ASGCT 2022 | Phio Pharmaceuticals
• Phio Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update | Phio Pharmaceuticals
• Phio Pharmaceuticals Announces Senior Leadership Personnel Change | Phio Pharmaceuticals
• Phio Pharmaceuticals Announces Trial-In-Progress Poster at ASCO 2022 | Phio Pharmaceuticals
• Phio Pharmaceuticals Announces Upcoming Presentation of PH-894 Data at ASGCT 25th Annual Meeting 2022 | Phio Pharmaceuticals
• Phio Pharmaceuticals Announces the Appointment of Patricia A. Bradford to its Board of Directors | Phio Pharmaceuticals
• Phio Pharmaceuticals Announces the Start of its Phase 1b Clinical Trial of PH-762 for the Treatment of Advanced Melanoma | Phio Pharmaceuticals
• Phio Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment Conference | Phio Pharmaceuticals
• View more press releases Close

Redes sociais sobre Phio Pharmaceuticals

• Phio Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
• Phio Pharmaceuticals na LinkedIn, X (Twitter) e YouTube